Home › Grants › United States › Clinical Characterization of Cancer Therapy-induced Adverse Sequelae a

Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to support collaborative research projects designed to address adverse sequelae of cancer therapies that persist and become chronic comorbidities or develop as delayed posttreatment effects.

Grant (non-repayable) Open now

Funder

National Institutes of Health
Funder profile and all of its programs

Amount

Award amounts are not published in the listing; see the official page.

Where

United States (federal)

Eligibility

Open to businesses, self-employed people, nonprofits, colleges, universities, schools or research institutions and state, provincial, local or tribal governments. No cost sharing is required.

Sectors

Education and training, Health and life sciences, Nonprofits and charities, Research and science

Deadline

Closes 7 January 2028

Source

Grants.gov XML extract (PAR-25-145)

Last checked

2 November 2026

Funder contacts

Public organizational contacts on file Unlock full profile / Sign up

Official page ↗

From official open data: listed in the official Grants.gov extract on 2026-11-02. The summary is from the official listing; the eligibility line is our plain-language reading of its eligibility codes. Confirm details on the official page.

Related grant lists

Education and training Health and life sciences Nonprofits and charities Governments and public bodies Schools, colleges and research institutions Nonprofits and charities United States United States (national) Federal agency January 2028

Information only. GrantSift is not affiliated with any funder. A match means a program is likely eligible or worth checking, not that you will be funded. Always confirm details on the official page. Applying through official portals is free.